Fig. 1From: Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagyChanges in metabolic indices in rats in the control, diabetes mellitus (DM), and diabetes mellitus + trimetazidine (DM + TMZ) groups (n = 5–6 per group). Changes in levels of total cholesterol (TC) (a), triglyceride (TG) (b), fasting blood glucose (FBG) (c), fasting insulin (FINS) (d), insulin sensitive index (ISI) (e), HDL-c (f) and LDL-c (g) are shown. Values are mean ± SEM. *p < 0.05 compared with control group; # p < 0.05 compared with diabetes group and & p < 0.05 compared with control groupBack to article page